Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Cowan

Showing results (271-280 of 522) with videos related to

Pageof 53
Sort By:
American Heart Journal|July 29, 2008
A randomized trial of the aldosterone-receptor antagonist eplerenone in asymptomatic moderate-severe aortic stenosisRalph A H Stewart, Andrew J Kerr, Brett R Cowan, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|October 14, 2017
Effects of age and exercise training on coronary microvascular smooth muscle phenotype and functionJudy M Muller-Delp, Kazuki Hotta, Bei Chen, et al.
Journal of Translational Medicine|November 5, 2015
Information maximizing component analysis of left ventricular remodeling due to myocardial infarctionXingyu Zhang, Bharath Ambale-Venkatesh, David A Bluemke, et al.
Bioorganic & Medicinal Chemistry Letters|October 10, 2002
Identification and structure-activity studies of novel ultrashort-acting benzodiazepine receptor agonistsJeffrey A Stafford, Gregory J Pacofsky, Richard F Cox, et al.
Vaccines|March 30, 2023
A Novel Vaccine Strategy to Prevent Cytauxzoonosis in Domestic CatsPabasara Weerarathne, Rebekah Maker, Chaoqun Huang, et al.
Psychiatric Services (Washington, D.C.)|December 13, 2023
Symptomatic and Functional Outcomes Among Individuals at High Risk for Psychosis Participating in Step-Based CareSarah A Hamilton, Heather M Wastler, Aubrey M Moe, et al.
Antimicrobial Agents and Chemotherapy|October 28, 2005
Anti-human immunodeficiency virus type 1 activity of the nonnucleoside reverse transcriptase inhibitor GW678248 in combination with other antiretrovirals against clinical isolate viruses and in vitro selection for resistanceRichard J Hazen, Robert J Harvey, Marty H St Clair, et al.
Diabetologia|January 28, 2009
A copper(II)-selective chelator ameliorates left-ventricular hypertrophy in type 2 diabetic patients: a randomised placebo-controlled studyG J S Cooper, A A Young, G D Gamble, et al.
Journal of Medicinal Chemistry|January 20, 2006
Structure-activity relationship studies of novel benzophenones leading to the discovery of a potent, next generation HIV nonnucleoside reverse transcriptase inhibitorKaren R Romines, George A Freeman, Lee T Schaller, et al.
Schizophrenia Bulletin|May 10, 2024
The Complex Latent Structure of Attenuated Psychotic Symptoms: Hierarchical and Bifactor Models of SIPS Symptoms Replicated in Two Large Samples at Clinical High Risk for PsychosisHenry R Cowan, Trevor F Williams, Vijay A Mittal, et al.
Pageof 53

Showing results (271-280 of 522) with videos related to

Sort By:
Pageof 53
American Heart Journal|July 29, 2008
A randomized trial of the aldosterone-receptor antagonist eplerenone in asymptomatic moderate-severe aortic stenosisRalph A H Stewart, Andrew J Kerr, Brett R Cowan, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|October 14, 2017
Effects of age and exercise training on coronary microvascular smooth muscle phenotype and functionJudy M Muller-Delp, Kazuki Hotta, Bei Chen, et al.
Journal of Translational Medicine|November 5, 2015
Information maximizing component analysis of left ventricular remodeling due to myocardial infarctionXingyu Zhang, Bharath Ambale-Venkatesh, David A Bluemke, et al.
Bioorganic & Medicinal Chemistry Letters|October 10, 2002
Identification and structure-activity studies of novel ultrashort-acting benzodiazepine receptor agonistsJeffrey A Stafford, Gregory J Pacofsky, Richard F Cox, et al.
Vaccines|March 30, 2023
A Novel Vaccine Strategy to Prevent Cytauxzoonosis in Domestic CatsPabasara Weerarathne, Rebekah Maker, Chaoqun Huang, et al.
Psychiatric Services (Washington, D.C.)|December 13, 2023
Symptomatic and Functional Outcomes Among Individuals at High Risk for Psychosis Participating in Step-Based CareSarah A Hamilton, Heather M Wastler, Aubrey M Moe, et al.
Antimicrobial Agents and Chemotherapy|October 28, 2005
Anti-human immunodeficiency virus type 1 activity of the nonnucleoside reverse transcriptase inhibitor GW678248 in combination with other antiretrovirals against clinical isolate viruses and in vitro selection for resistanceRichard J Hazen, Robert J Harvey, Marty H St Clair, et al.
Diabetologia|January 28, 2009
A copper(II)-selective chelator ameliorates left-ventricular hypertrophy in type 2 diabetic patients: a randomised placebo-controlled studyG J S Cooper, A A Young, G D Gamble, et al.
Journal of Medicinal Chemistry|January 20, 2006
Structure-activity relationship studies of novel benzophenones leading to the discovery of a potent, next generation HIV nonnucleoside reverse transcriptase inhibitorKaren R Romines, George A Freeman, Lee T Schaller, et al.
Schizophrenia Bulletin|May 10, 2024
The Complex Latent Structure of Attenuated Psychotic Symptoms: Hierarchical and Bifactor Models of SIPS Symptoms Replicated in Two Large Samples at Clinical High Risk for PsychosisHenry R Cowan, Trevor F Williams, Vijay A Mittal, et al.
Pageof 53